Exostosin 2 (EXT2) (C-Term) Peptide
-
- Target See all EXT2 products
- EXT2 (Exostosin 2 (EXT2))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- LTYDRVESLF RVITEVSKVP SLSKLLVVWN NQNKNPPEDS LWPKIRVPLK
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-EXT2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- EXT2 (Exostosin 2 (EXT2))
- Synonyms
- SOTV Peptide, AI893565 Peptide, EXT2 Peptide, ext2 Peptide, exostosin glycosyltransferase 2 Peptide, exostoses (multiple) 2 Peptide, exostoses (multiple) 3 Peptide, exostosin glycosyltransferase 2 L homeolog Peptide, EXT2 Peptide, Ext2 Peptide, EXT3 Peptide, ext2.L Peptide
- Background
-
This gene encodes one of two glycosyltransferases involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type II form of multiple exostoses. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.
Alias Symbols: EXT2,
Protein Size: 718 - Gene ID
- 2132
- NCBI Accession
- NP_997005
- UniProt
- Q93063
-